Restore Mind Medicine

We believe MindMed has tremendous potential, and under new shareholder aligned leadership and the right clinical strategy, it could be well-positioned to capitalize on the massive opportunities in the psychedelic medicine sector over the next several years. J - Dr. Scott Freeman, FCM Nominee and MindMed Co-Founder 5

View entire presentation